Results for neovascularisation translation from Maltese to English

visudyne jintuża għat- trattament ta ’ pazjenti li jkollhom subfoveal choroidal neovascularisation.
visudyne is used for the treatment of patients who have subfoveal choroidal neovascularisation.

visudyne ġie studjat ukoll għal sentejn fuq 120 pazjent b’ subfoveal choroidal neovascularisation ikkawżata minn mijopija patoloġika.
visudyne has also been studied for two years in 120 patients with subfoveal choroidal neovascularisation caused by pathologic myopia.

fiż- żewġ studji ta ’ subfoveal choroidal neovascularisation klassika, visudyne kien iktar effettiv mill - plaċebo.
in the two studies of classic subfoveal choroidal neovascularisation, visudyne was more effective than placebo.

deġenerazzjoni makulari relatata mal-età neovaskulari (imxarrba) (amd imxarrba - wet age- related macular degeneration), indeboliment fil-vista kkawżat minn edima makulari sekondarja għall-okklużjoni tal-vina tar- retina (rvo ta’ vini sekondarji (brvo - branch retinal vein occlusion) jew rvo tal-vina ċentrali (crvo - central retinal vein occlusion), indeboliment fil-vista kkawżat minn edima makulari dijabetika (dme - diabetic macular oedema). indeboliment fil-vista kkawżat minn neovaskularizzazzjoni korojdali mijopika (cnv mijopika - myopic choroidal neovascularisation)
neovascular (wet) age-related macular degeneration (wet amd), impaired vision due to macular oedema secondary to retinal vein occlusion (branch rvo (brvo) or central rvo (crvo)), impaired vision due to diabetic macular oedema (dme), impaired vision due to myopic choroidal neovascularisation (myopic cnv).